Interleukin-18 and interferon-gamma polymorphisms are implicated on proviral load and susceptibility to human T-lymphotropic virus type 1 infection


Autoria(s): Rocha Júnior, Maurício Cristiano; Haddad, Rodrigo; Alves, Daiani Cristina Cilião; Wagatsuma, Virginia Mara de Deus; Mendes Junior, Celso Teixeira; Deghaide, N. H. S.; Takayanagui, Osvaldo Massaiti; Covas, Dimas Tadeu; Donadi, Eduardo Antonio; Kashima, S.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

07/11/2013

07/11/2013

2012

Resumo

Interleukin-18 (IL-18) and interferon-gamma (IFN-?) exert important functions in both innate and adaptive immune responses against intracellular pathogens and viruses. Previous studies suggested that host genetic factors, including cytokines gene polymorphisms, could be involved in the pathogenesis of human T-cell leukemia virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Thus, we analyzed -137C/G and -607A/C of the IL-18 promoter and +874T/A of the IFN-? in DNA samples from 98 HTLV-1-infected individuals exhibiting or not clinical symptoms and 150 healthy control individuals. The IL-18 promoter -607CC genotype was significantly lower in HTLV-1 asymptomatic carriers (HAC) and HTLV-1-infected individuals (HAC + HAM/TSP) than healthy control group. In contrast, the -607AC genotype was significantly higher in HAC and HTLV-1-infected individuals group compared to the healthy control group. The -137G/-607A IL-18 haplotype was higher in infected group than healthy control group, and the -137C/-607C IL-18 haplotype was increased in the healthy control group compared to the others. Finally, the IFN-? polymorphism analysis showed that the HTLV-1-infected individuals with +874AT genotype presented higher proviral load than +874AA genotype. These data indicate that the IL-18-607AC genotype and -137G/-607A haplotype could be a risk factor for HTLV-1 infection, whereas the protective effect could be conferred by -607CC genotype and -137C/-607C haplotype. Also, the IFN-? could be implicated on the proviral load levels.

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)

Centro de Terapia Celular da Fundacao Hemocentro de Ribeirao Preto (CTC/FUNDHERP)

Instituto Nacional de Ciência e Tecnologia em Células-Tronco e Terapia Celular (INCTC)

Identificador

TISSUE ANTIGENS, HOBOKEN, v. 80, n. 2, p. 143-150, AUG, 2012

0001-2815

http://www.producao.usp.br/handle/BDPI/43204

10.1111/j.1399-0039.2012.01887.x

http://dx.doi.org/10.1111/j.1399-0039.2012.01887.x

Idioma(s)

eng

Publicador

WILEY-BLACKWELL

HOBOKEN

Relação

TISSUE ANTIGENS

Direitos

restrictedAccess

Copyright WILEY-BLACKWELL

Palavras-Chave #HUMAN T-CELL LEUKEMIA VIRUS TYPE 1 INFECTION #INTERLEUKIN-18 #INTERFERON-GAMMA #POLYMORPHISMS #I-ASSOCIATED MYELOPATHY #CHRONIC HEPATITIS-B #TROPICAL SPASTIC PARAPARESIS #HTLV-I #GENE POLYMORPHISMS #PROMOTER POLYMORPHISM #HIV-1 INFECTION #IL-18 PROMOTER #LIVER-DISEASE #ASSOCIATION #CELL BIOLOGY #IMMUNOLOGY #PATHOLOGY
Tipo

article

original article

publishedVersion